India Glycols Ltd (BOM:500201)
₹ 1149.1 -15.4 (-1.32%) Market Cap: 35.58 Bil Enterprise Value: 48.31 Bil PE Ratio: 19.52 PB Ratio: 1.74 GF Score: 77/100

Q1 2025 India Glycols Ltd Earnings Call Transcript

Jul 31, 2024 / 10:30AM GMT
Release Date Price: ₹1209.8 (+2.00%)

Key Points

Positve
  • Gross revenue increased by 21% to INR2,283 crore.
  • Net revenue surged by 41% to INR969 crore.
  • EBITDA rose by 21% to INR128 crore.
  • PAT margin improved by 18%.
  • Biofuels business showed significant growth, with revenue increasing from INR65 crore to INR139 crore.
Negative
  • Finance costs remain high at INR35 crore, impacting overall profitability.
  • Ennature Biopharma segment experienced margin pressure due to cost increases in nicotine and Thiocolchicoside.
  • Despite revenue growth, the potable spirits segment's EBIT margin slightly decreased.
  • The company has taken on fresh borrowings of INR165 crore, increasing its debt burden.
  • Grain prices and other cost pressures continue to affect the biofuels segment's margins.
Operator

Good evening, ladies and gentlemen. I'm Pelsia, moderator for the conference call. Welcome to India Glycols Limited Q1 FY25 earnings conference call hosted by Sunidhi Securities. (Operator Instructions) Please note that this conference is recorded.

I would now like to hand over the floor to Rohit Sinha from Sunidhi Securities. Thank you, and over to you, sir.

Rohit Sinha
Sunidhi Securities - Analyst

Good evening, everyone. Thank you for joining us on India Glycols Limited Q1 FY25 results conference call. I would like to thank the management for giving us this opportunity to host the call and congratulate them for good set of numbers.

We are joined on this call with India Glycols management, represented by Mr. Rupark Sarswat, Chief Executive Officer; Mr. Anand Singhal, Chief Financial Officer; Mr. Rajesh Marwaha, Head Sales and Marketing, BSPC; Mr. S.K. Shukla, Head Liquor business; and Mr. Ankur Jain, Head Legal and Company Secretary.

I would like to invite Mr. Rupark Sarswat sir to initiate these proceedings with his opening

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot